WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO1999032443) MUSCARINIC AGENTS AND USE THEREOF TO TREAT GLAUCOMA, MYOPIA, AND VARIOUS OTHER CONDITIONS
Latest bibliographic data on file with the International Bureau   

Pub. No.: WO/1999/032443 International Application No.: PCT/US1998/027586
Publication Date: 01.07.1999 International Filing Date: 22.12.1998
Chapter 2 Demand Filed: 22.07.1999
IPC:
C07D 211/46 (2006.01) ,C07D 211/56 (2006.01)
Applicants: SEVERNS, Bryon, S.[US/US]; US (UsOnly)
HELLBERG, Mark, R.[US/US]; US (UsOnly)
NAMIL, Abdelmoula[FR/US]; US (UsOnly)
DEAN, Thomas, R.[US/US]; US (UsOnly)
HOFFMAN, Andrew[US/US]; US (UsOnly)
ALCON LABORATORIES, INC.[US/US]; 6201 South Freeway Mail Code Q-148 Fort Worth, TX 76134-2099, US (AllExceptUS)
Inventors: SEVERNS, Bryon, S.; US
HELLBERG, Mark, R.; US
NAMIL, Abdelmoula; US
DEAN, Thomas, R.; US
HOFFMAN, Andrew; US
Agent: BROWN, Gregg, C. ; Alcon Laboratories, Inc. R & R Counsel, Mail Code Q-148 6201 South Freeway Fort Worth, TX 76134-2099, US
Priority Data:
60/068,62623.12.1997US
Title (EN) MUSCARINIC AGENTS AND USE THEREOF TO TREAT GLAUCOMA, MYOPIA, AND VARIOUS OTHER CONDITIONS
(FR) AGENTS MUSCARINIQUES ET LEUR UTILISATION POUR TRAITER LE GLAUCOME, LA MYOPIE, ET D'AUTRES DYSFONCTIONNEMENTS
Abstract:
(EN) A new group of compounds having muscarinic activity is disclosed. The use of the compounds and pharmaceutically acceptable salts thereof to treat glaucoma, myopia, psychosis and various other conditions involving muscarinic receptors is also disclosed.
(FR) L'invention concerne un nouveau groupe de composés présentant une activité muscarinique. L'invention concerne également l'utilisation de ces composés, et des sels pharmaceutiquement acceptables de ceux-ci, pour traiter le glaucome, la myopie, la psychose, et d'autres dysfonctionnement faisant intervenir des récepteurs muscariniques.
Designated States: AU, BR, CA, CN, JP, KR, MX, US
European Patent Office (EPO) (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
Publication Language: English (EN)
Filing Language: English (EN)